H Lundbeck A/S

Common Name

H Lundbeck

Country

Denmark

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

5,700

Ticker

HLUN A

Exchange

NASDAQ COPENHAGEN A/S

Website

www.lundbeck.com

Description

H. Lundbeck A/S engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and inter... Show more

Financial Statements of H Lundbeck

Below are the financial statements of H Lundbeck, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Income Statement (as reported) Balance Sheet (as reported)

All figures in millions of DKK	2024	2023
Intangible assets	40,167^a	20,692^a
Property, plant and equipment	2,721^a	2,499^a
Right-of-use assets	461^a	382^a
Other financial assets	67^a	99^a
Other receivables	284^a	208^a
Deferred tax assets	266^a	238^a
Financial and other assets	617^a	545^a
Non-current assets	43,966^a	24,118^a
Inventories	3,983^a	4,427^a
Trade receivables	3,432^a	2,965^a
Income taxes receivable	39^a	73^a
Other receivables	552^a	588^a
Prepayments	340^a	226^a
Receivables	4,363^a	3,852^a
Cash and cash equivalents	4,664^a	5,010^a
Current assets	13,010^a	13,289^a
Assets	56,976^a	37,407^a
Share capital	996^a	996^a
Foreign currency translation reserve	1,888^a	1,109^a
Hedging reserve	-208^a	63^a
Retained earnings	22,334^a	19,877^a
Equity	25,010^a	22,045^a
Retirement benefit obligations	223^a	216^a
Deferred tax liabilities	5,530^a	2,283^a
Provisions	583^a	388^a
Bank debt and bond debt	16,174^a	3,714^a
Lease liabilities	437^a	351^a
Other payables	439^a	420^a
Non-current liabilities	23,386^a	7,372^a
Retirement benefit obligations	1^a	1^a
Provisions	1,351^a	934^a
Trade payables	4,370^a	4,410^a
Lease liabilities	82^a	86^a
Income taxes payable	316^a	571^a
Other payables	2,460^a	1,988^a
Current liabilities	8,580^a	7,990^a
Liabilities	31,966^a	15,362^a
Equity and liabilities	56,976^a	37,407^a

Verified Sources Behind H Lundbeck’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore H Lundbeck’s data sources below and access millions more through our Disclosure Search.

a. H Lundbeck's Annual Report 2024

Trace every data point back to H Lundbeck’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

At Tracenable, we're exploring the launch of real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

Welcome Back to Tracenable

Sign in to your account

H Lundbeck A/S

Financial Statements of H Lundbeck

Verified Sources Behind H Lundbeck’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

Genmab A/S

Ascendis Pharma A/S

Ambu A/S

Demant A/S

Novo Nordisk A/S

Coloplast A/S